Autres langues COSMOS Pharmaceutical Corporation

Actions

3349

JP3298400007

Pharmacies

Temps Différé Japan Exchange Autres places de cotation 08:30:00 05/08/2026			Varia. 5j.	Varia. 1 janv.
6 250,00 ^JPY	-0,97%		-10,77%	-21,31%

13/07	COSMOS Pharmaceutical Corporation publie ses prévisions de dividendes pour l'exercice clos au 31 mai 2027	CI
13/07	COSMOS Pharmaceutical Corporation publie ses prévisions de résultats consolidés pour le premier semestre et l'exercice complet clôturant au 31 mai 2027	CI

Autres langues

13/07	COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2027
13/07	COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of the Fiscal Year Ending May 31, 2027
13/07	Cosmos Pharmaceutical Corporation Announces Dividend for the Fiscal Year Ended May 31, 2026, Payable on August 10, 2026; Provides Dividend Guidance for the Second Quarter-End of the Fiscal Year Ending May 31, 2027
13/07	COSMOS Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended May 31, 2026
13/04	Cosmos Pharmaceutical's Nine-Month Profit Rises 1.8%
13/04	Cosmos Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2026
13/04	COSMOS Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended February 28, 2026
13/01	Cosmos Pharmaceutical's Attributable Profit Up 1.5% in Fiscal H1
13/01	Cosmos Pharmaceutical Corporation Announces Dividend for the Second Quarter-End of the Fiscal Year Ending May 31, 2026, Payable on February 12, 2026
14/10/25	Cosmos Pharmaceutical's Attributable Profit Up 0.3% in Fiscal Q1
27/08/25	Cosmos Pharma Weighs Cutting Investment Unit to Boost Liquidity
11/07/25	Cosmos Pharmaceutical's Full-Year Profit Climbs 27%
11/07/25	COSMOS Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended May 31, 2025
11/07/25	COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Fiscal Year Ended May 31, 2025, Payable on August 4, 2025
11/07/25	COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Second Quarter-End of Fiscal Year Ending May 31, 2026
11/07/25	COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2026
11/07/25	COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2026
16/01/25	Cosmos Pharmaceutical's Attributable Profit Jumps 25% in Fiscal H1
14/01/25	Cosmos Pharmaceutical's Attributable Profit Jumps 25% in Fiscal H1; Shares Rise 6%
10/01/25	Cosmos Pharmaceutical Corporation Announces Dividend for the Second Quarter-End of Fiscal Year Ending May 31, 2025, Payable on February 12, 2025
11/10/24	Cosmos Pharmaceutical's Profit Swells 25% in Fiscal Q1
25/07/24	Ethereum Spot ETF: un lancio fallito?
12/07/24	COSMOS Pharmaceutical's Attributable Profit Gains Nearly 3% in Fiscal 2024
12/07/24	COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Fiscal Year Ended May 31, 2024, Payable on August 1, 2024; Provides Second Quarter End and Year End Dividend Guidance for the Fiscal Year Ending May 31, 2025
12/07/24	COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2025